- Home
- BHST vs CLYM Comparison
BHST vs CLYM Comparison
Compare BHST & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- CLYM
- Stock Information
- Founded
- BHST 2007
- CLYM 2018
- Country
- BHST Canada
- CLYM United States
- Employees
- BHST N/A
- CLYM 18
- Industry
- BHST
- CLYM
- Sector
- BHST
- CLYM
- Exchange
- BHST Nasdaq
- CLYM NYSE
- Market Cap
- BHST 106.0M
- CLYM 86.5M
- IPO Year
- BHST N/A
- CLYM 2021
- Fundamental
- Price
- BHST $7.06
- CLYM $1.22
- Analyst Decision
- BHST Strong Buy
- CLYM Buy
- Analyst Count
- BHST 2
- CLYM 1
- Target Price
- BHST $13.00
- CLYM $10.00
- AVG Volume (30 Days)
- BHST 11.9K
- CLYM 200.0K
- Earning Date
- BHST 08-15-2025
- CLYM 08-13-2025
- Dividend Yield
- BHST N/A
- CLYM N/A
- EPS Growth
- BHST N/A
- CLYM N/A
- EPS
- BHST N/A
- CLYM N/A
- Revenue
- BHST $27,704,000.00
- CLYM N/A
- Revenue This Year
- BHST $116.40
- CLYM N/A
- Revenue Next Year
- BHST $55.91
- CLYM N/A
- P/E Ratio
- BHST N/A
- CLYM N/A
- Revenue Growth
- BHST 74.76
- CLYM N/A
- 52 Week Low
- BHST $4.66
- CLYM $1.05
- 52 Week High
- BHST $7.86
- CLYM $9.21
- Technical
- Relative Strength Index (RSI)
- BHST N/A
- CLYM N/A
- Support Level
- BHST N/A
- CLYM N/A
- Resistance Level
- BHST N/A
- CLYM N/A
- Average True Range (ATR)
- BHST 0.00
- CLYM 0.00
- MACD
- BHST 0.00
- CLYM 0.00
- Stochastic Oscillator
- BHST 0.00
- CLYM 0.00
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.